Shanghai Renyoung Pharmaceutical Co., Ltd. is a professional manufacturer and trading company established in 2004 and headquartered in Shanghai, China. The company specializes in the research, development, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and plant extracts. With a workforce of 101 to 200 employees, including a dedicated R&D team, the company operates as a commercial bridge between domestic chemical factories and global pharmaceutical markets. Their core product portfolio includes Lumefantrine, Tigecycline, Febuxostat, and a wide range of specialized compounds such as steroids, peptides, SARMs, and CBD products. Renyoung Pharmaceutical maintains a strong focus on quality and compliance, holding certifications such as ISO 9001, GMP, CE, UL, and ASME. The company shares holdings in manufacturing facilities that feature cGMP-compliant workshops and synthesis capabilities ranging from laboratory to industrial scales. They offer comprehensive contract manufacturing services, including OEM, ODM, and custom synthesis for highly specialized chemical intermediates. Their global distribution network extends to over 40 countries across North America, Europe, Asia, and Africa, serving a diverse clientele with high-specification agrochemical ingredients, food additives, and dietary supplements.
Screw Air Compressor 10hp$3000
Shanghai Marya Pharmaceutical Engineering and Project Co., Ltd.